psilocin has been researched along with Sensitivity and Specificity in 8 studies
psilocin: psilocybine minus the phosphate ester; RN given refers to parent cpd; structure
psilocin : A tryptamine alkaloid that is N,N-dimethyltryptamine carrying an additional hydroxy substituent at position 4. A hallucinogenic alkaloid isolated in trace amounts from Psilocybe mushrooms (also known as Teonanacatl or "magic mushrooms").
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Excerpt | Relevance | Reference |
---|---|---|
" The pharmacokinetic parameters of psilocin in rat plasma after the oral administration of a G." | 1.37 | Determining the pharmacokinetics of psilocin in rat plasma using ultra-performance liquid chromatography coupled with a photodiode array detector after orally administering an extract of Gymnopilus spectabilis. ( Chen, J; Chu, VM; Kang, JS; Lee, KJ; Lee, W; Li, M; Wu, E; Yan, X; Zhan, L; Zhu, H, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Kolaczynska, KE | 1 |
Liechti, ME | 1 |
Duthaler, U | 1 |
Chen, J | 1 |
Li, M | 1 |
Yan, X | 1 |
Wu, E | 1 |
Zhu, H | 1 |
Lee, KJ | 1 |
Chu, VM | 1 |
Zhan, L | 1 |
Lee, W | 1 |
Kang, JS | 1 |
Martin, R | 1 |
Schürenkamp, J | 1 |
Gasse, A | 1 |
Pfeiffer, H | 1 |
Köhler, H | 2 |
Kamata, T | 2 |
Nishikawa, M | 2 |
Katagi, M | 2 |
Tsuchihashi, H | 2 |
Albers, C | 1 |
Lehr, M | 1 |
Brinkmann, B | 1 |
Beike, J | 1 |
Keller, T | 1 |
Schneider, A | 1 |
Regenscheit, P | 1 |
Dirnhofer, R | 1 |
Rücker, T | 1 |
Jaspers, J | 1 |
Kisser, W | 1 |
Grieshaber, AF | 1 |
Moore, KA | 1 |
Levine, B | 1 |
8 other studies available for psilocin and Sensitivity and Specificity
Article | Year |
---|---|
Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin's main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma.
Topics: Administration, Oral; Chromatography, Liquid; Hallucinogens; Humans; Hydroxyindoleacetic Acid; Linea | 2021 |
Determining the pharmacokinetics of psilocin in rat plasma using ultra-performance liquid chromatography coupled with a photodiode array detector after orally administering an extract of Gymnopilus spectabilis.
Topics: Administration, Oral; Agaricales; Animals; Area Under Curve; Chromatography, High Pressure Liquid; D | 2011 |
Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.
Topics: Adult; Bufotenin; Case-Control Studies; Chromatography, Liquid; Female; Forensic Toxicology; Halluci | 2013 |
Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples.
Topics: Adolescent; Chromatography, High Pressure Liquid; Female; Glucuronides; Hallucinogens; Humans; Hydro | 2003 |
Development of a psilocin immunoassay for serum and blood samples.
Topics: Animals; Hallucinogens; Humans; Psilocybin; Rabbits; Radioimmunoassay; Sensitivity and Specificity; | 2004 |
Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples.
Topics: Agaricales; Chromatography, Liquid; Forensic Medicine; Hallucinogens; Mass Spectrometry; Psilocybin; | 2005 |
Analysis of psilocybin and psilocin in Psilocybe subcubensis Guzmán by ion mobility spectrometry and gas chromatography-mass spectrometry.
Topics: Agaricales; Drug and Narcotic Control; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hall | 1999 |
The detection of psilocin in human urine.
Topics: Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Psilocybin; Sensitiv | 2001 |